US biotech firms line up to list in Korea lured by strong valuations

US biotech firms line up to list in Korea lured by strong valuations

Laboratory equipment. Photo: Pixabay

U.S. biotech firms are queuing up to list in South Korea, tempted by the promise of strong valuations amid a welcoming base of investors.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter